Related Experiment Video
Updated: Aug 17, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Apoptotic efficacy and inhibitory effect of dexamethasone on matrix metalloproteinase
Farshid Saadat1, Mohammad Reza Khorramizadeh, Abbas Mirshafiey
1Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Background:
There is now accumulating evidence that matrix metalloproteinases and apoptosis may play an important role in inflammation processes. This study was undertaken to determine the effect of dexamethasone on apoptosis and matrix metalloproteinase 2 (MMP-2) activity compared with two nonsteroidal anti-inflammatory drugs (NSAIDs), piroxicam and diclofenac.
Material/Methods:
A fibrosarcoma (WEHI-164) cell line was used for evaluating tolerability, MMP-2 activity, and apoptosis. Dexamethasone, piroxicam, and diclofenac were used at concentrations of 10-200 microg/ml in triplicate, two-fold dilutions. MMP-2 activity was assessed using zymography. For assessment of apoptosis, terminal deoxyribonucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) was used.
Results:
Cytotoxicity analysis of dexamethasone showed a greater tolerability than diclofenac at concentrations of 10-100 microg/ml, whereas the cytotoxic effect of dexamethasone and piroxicam were parallel at doses of 5-80 microg/ml. The dose-dependent inhibitory effect of dexamethasone on MMP-2 activity was significantly less than that of the tested NSAIDs at concentrations of 10-80 microg/ml, while it increased at doses of >100 microg/ml compared with piroxicam. Moreover, the rate of apoptosis for dexamethasone-treated cells was 20.92%, the values for diclofenac and piroxicam being 78% and 28.15%, respectively.
Conclusions:
Our findings suggest that dexamethasone is able to induce apoptosis and suppress MMP-2 activity. Collectively, dexamethasone might be assumed as an agent which could be recommended for chemopreventive purposes.
Insights
Dexamethasone demonstrated apoptosis induction and matrix metalloproteinase 2 (MMP-2) suppression, suggesting its potential for chemoprevention. Nonsteroidal anti-inflammatory drugs (NSAIDs) showed greater MMP-2 inhibition but induced more apoptosis.
Area of Science:
- Biochemistry
- Pharmacology
- Cell Biology
Background:
- Matrix metalloproteinases (MMPs) and apoptosis are implicated in inflammatory processes.
- This study investigates the effects of dexamethasone, piroxicam, and diclofenac on MMP-2 activity and apoptosis.
Purpose of the Study:
- To compare the effects of dexamethasone with NSAIDs (piroxicam, diclofenac) on apoptosis and MMP-2 activity.
- To evaluate the potential chemopreventive role of dexamethasone.
Main Methods:
- Utilized a fibrosarcoma (WEHI-164) cell line for tolerability, MMP-2 activity, and apoptosis assessments.
- Administered dexamethasone, piroxicam, and diclofenac at varying concentrations (10-200 microg/ml).
- Assessed MMP-2 activity via zymography and apoptosis using terminal deoxyribonucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL).
Main Results:
- Dexamethasone exhibited better tolerability than diclofenac at 10-100 microg/ml.
- NSAIDs showed a more potent dose-dependent inhibition of MMP-2 activity compared to dexamethasone at 10-80 microg/ml.
- Dexamethasone induced 20.92% apoptosis, compared to 78% for diclofenac and 28.15% for piroxicam.
Conclusions:
- Dexamethasone effectively induces apoptosis and suppresses MMP-2 activity.
- Dexamethasone shows promise as a chemopreventive agent.
- NSAIDs were more effective at inhibiting MMP-2 but induced higher rates of apoptosis.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
Caspases
The Extrinsic Apoptotic Pathway
